Troponin and BNP in the Diagnosis of Pulmonary Hypertension

Save

Common cardiac biomarkers could be used to identify patients with systemic sclerosis (SSc) at risk for developing pulmonary hypertension, French researchers reported.

Microscopic Polyangiitis Associated with Pulmonary Fibrosis

Save

Brain Natriuretic Peptide Measurement in Rheumatoid Arthritis

Save

Cardiovascular (CV) risk and adverse cardiac outcomes are common in rheumatoid arthritis (RA). It has been presumed that chronic systemic inflammation has a deleterious effect on the myocardium and vasculature, thereby leading to higher rates of MI, CHF and CV death.

Targeting Autoantibodies in Idiopathic Pulmonary Fibrosis

Save

Idiopathic pulmonary fibrosis carries a high mortality rate and can be a management challenge. Moreover, exacerbations of IPF may be fatal. A multicenter uncontrolled study examined the utility of targeting autoantibody production with revealed surprising results.

The EULAR 2015 Report- Friday

Save

These abstracts and presentations were presented 12 June at the EULAR 2015 annual meeting.

Allopurinol Reduces Mortality in Gout

Save

CVD risk is significantly augmented in gout. Choi and coworkers studied this issue using a UK general population database using an incident user cohort study with propensity score matching.

Difficulties Diagnosing Interstitial Lung Disease in Scleroderma

Save

The diagnosis of chronic lung disease in patients with systemic sclerosis may be difficult because of atypical symptoms, variable evolution and limitations of current classification criteria for a definite diagnosis. Nevertheless, diagnosis is necessary as patients with SSc-ILD have a p

Early DMARD Therapy Averts Cardiovascular Risk in RA

Save

A Finnish early RA register studied 14,878 incident RA patients from 2000-2008 and identified 1157 deaths.  Patients receiving DMARDs and MTX had lower mortality rates. The standardized moratility ratio for the entire cohort was reduced (0.57, 95% CI 0.52 to 0.62).